PerkinElmer Streamlines Flow Cytometry Management For Biopharmaceutical Labs with New OneSource Concierge Service

WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that it has added PerkinElmer Flow Cytometry Instrument Concierge Services to its OneSource® Laboratory Services portfolio. The comprehensive and flexible offering will provide biopharmaceutical labs with expert, onsite flow cytometry specialists to help manage their instruments and processes more efficiently... Read more

Ellutia introduces fully automated total nitrosamine testing for pharmaceuticals at Analytica 2022

Ely, Cambridgeshire, 21st June, 2022: The Ellutia 800 Series Thermal EnergyAnalyser (TEA) has become the industry standard for nitrosamine detection thanks toits selectivity and sensitivity for nitroso compounds. For testing of pharmaceuticaldrugs, the 800 Series TEA can be interfaced to a chemical stripping system thatallows for rapid testing of apparent total nitrosamine content (ATNC). This... Read more

Bruker Acquires Optimal Companies for Pharma PAT Software and Biopharma Manufacturing Automation Expertise and Technologies

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of Optimal Industrial Automation and Technologies, a leader in pharma and biopharma process analytical technology (PAT), pharma manufacturing automation and Quality Assurance (QA) software and systems integration, based in the United Kingdom. The Optimal biopharma tools acquisition strengthens Bruker as a key software and... Read more

GE Healthcare Receives FDA Approval of First-Ever Software to Help Automate Anesthesia Delivery and Reduce Greenhouse Gas Emissions During Surgery

CHICAGO – April 4, 2022 – GE Healthcare announced today the FDA pre-market approval (PMA) for its End-tidal (Et) Control software for general anesthesia delivery on its Aisys CS2Anesthesia Delivery System. GE Healthcare is the only manufacturer approved to offer general anesthesia delivery with end-tidal concentration control in the U.S. The company initially released the... Read more

GE Healthcare announces first patient dosed in phase III clinical trial for new dopamine transporter imaging radiopharmaceutical

First patient dosed in Phase III clinical trial for PET radiopharmaceutical Next stage clinical study also proceeding for SPECT radiopharmaceutical Both imaging agents aim to assist in the evaluation of adult patients with suspected Parkinsonian syndromes, support research and improve patient care Builds on market leadership with SPECT agent DaTscan™ (Ioflupane I 123 Injection), to... Read more

Announcing New Fourier 80 Benchtop FT-NMR Capabilities for Pharmaceutical and Food Analysis Markets

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announces new capabilities for its benchtop Fourier transform (FT) nuclear magnetic resonance (NMR) spectrometer, the Fourier 80, which does not require special lab infrastructure or cryogens, and offers excellent 1H sensitivity of 200:1 for gradient spectroscopy proton probes. A new adjustable temperature option increases experimental flexibility, while... Read more